Skip to content

Drug interactions

Repotrectinib + Sirolimus

Severity: Major

Repotrectinib and Sirolimus: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib induces CYP3A4 and can reduce sirolimus exposure. Loss of immunosuppressive effect may result in rejection.

What this interaction means in plain words

Repotrectinib and Sirolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Repotrectinib belongs to Oncology; Sirolimus belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 increases sirolimus metabolism.

What to do

Avoid combination if possible. If unavoidable, monitor sirolimus troughs and adjust the dose upward.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Repotrectinib and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Repotrectinib with Sirolimus?

MediHelp rates the interaction as major. Repotrectinib and Sirolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Repotrectinib induces CYP3A4 and can reduce sirolimus exposure. Loss of immunosuppressive effect may result in rejection.

How serious is the interaction between Repotrectinib and Sirolimus?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combination if possible. If unavoidable, monitor sirolimus troughs and adjust the dose upward.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in